Literature DB >> 2339832

Tracheal mucus rheology in patients undergoing diagnostic bronchoscopy. Interrelations with smoking and cancer.

J G Zayas1, G C Man, M King.   

Abstract

We examined the differences in tracheal mucus rheology between nonsmokers and smokers, and between smokers with and without lung cancer. Mucus was collected from patients undergoing diagnostic bronchoscopy without atropine by holding a cytology brush in contact with the tracheal mucosa for 10 to 15 s. Samples were obtained from 43 patients 24 to 79 yr of age: nine nonsmokers, 18 current smokers, and 16 exsmokers (greater than 6 months); 12 patients (nine smokers, three exsmokers) had lung cancer. Pulmonary function testing showed that the nonsmoker patients had significant restrictive lung disease, and the patients with cancer had significant irreversible airway obstruction. The viscoelastic properties of the mucus samples were determined by magnetic microrheometry. Two parameters are reported: G* (modulus of rigidity) and tan delta (loss tangent), each measured at 1 and 100 rad/s. G* is an index of overall deformability (elastic and viscous), and tan delta is the ratio of viscous to elastic deformability. For nonsmoker patients, the viscoelastic parameters were virtually identical to those found previously for normal volunteers. For smokers without cancer, the mucus had a lower value of tan delta 1 rad/s and therefore was predicted to be more easily transportable by ciliary action; for exsmokers without cancer, ciliary transportability as calculated from viscoelasticity was even higher because of both low tan delta and low G*. Mucus from patients with cancer was not significantly different from that of nonsmokers; however, the mucus was predicted to be less easily clearable by ciliary action than was that from smokers and exsmokers without cancer, mainly because of a higher tan delta at 1 rad/s.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2339832     DOI: 10.1164/ajrccm/141.5_Pt_1.1107

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.

Authors:  Susanne R Youngren-Ortiz; David B Hill; Peter R Hoffmann; Kenneth R Morris; Edward G Barrett; M Gregory Forest; Mahavir B Chougule
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-03-09       Impact factor: 2.849

Review 2.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

3.  Synthetic tracheal mucus with native rheological and surface tension properties.

Authors:  R Hamed; J Fiegel
Journal:  J Biomed Mater Res A       Date:  2013-06-29       Impact factor: 4.396

Review 4.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

5.  Cough aerosol in healthy participants: fundamental knowledge to optimize droplet-spread infectious respiratory disease management.

Authors:  Gustavo Zayas; Ming C Chiang; Eric Wong; Fred MacDonald; Carlos F Lange; Ambikaipakan Senthilselvan; Malcolm King
Journal:  BMC Pulm Med       Date:  2012-03-21       Impact factor: 3.317

6.  Viscoelastic properties of Pseudomonas aeruginosa variant biofilms.

Authors:  Erin S Gloag; Guy K German; Paul Stoodley; Daniel J Wozniak
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.996

7.  Mycobacterium abscessus biofilms have viscoelastic properties which may contribute to their recalcitrance in chronic pulmonary infections.

Authors:  Erin S Gloag; Daniel J Wozniak; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

Review 8.  Biofilm aggregates and the host airway-microbial interface.

Authors:  Luanne Hall-Stoodley; Karen S McCoy
Journal:  Front Cell Infect Microbiol       Date:  2022-08-23       Impact factor: 6.073

9.  Adaptation of an amphibian mucociliary clearance model to evaluate early effects of tobacco smoke exposure.

Authors:  J Gustavo Zayas; Darryl W O'Brien; Shusheng Tai; Jie Ding; Leonard Lim; Malcolm King
Journal:  Respir Res       Date:  2004-08-20

10.  Genotypes in matrix metalloproteinase 9 are a risk factor for COPD.

Authors:  Yohannes Tesfaigzi; Orrin B Myers; Christine A Stidley; Kurt Schwalm; Maria Picchi; Richard E Crowell; Frank D Gilliland; Steven A Belinsky
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.